Loading clinical trials...
Loading clinical trials...
Evaluating Non-Invasive Approaches for Screening, Diagnosis, and Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Bariatric Patients & Identifying Biomarkers for Predicting Type 2 Diabetes Remission
Conditions
Interventions
Bariatric Surgery
Locations
2
Bahrain
Alhakeem Radiology Center
Manama, Manama, Bahrain
King Hamad University Hospital
Al Muharraq, Muharraq, Bahrain
Start Date
January 1, 2025
Primary Completion Date
December 31, 2026
Completion Date
June 30, 2027
Last Updated
September 15, 2025
NCT07440511
NCT06843148
NCT07321678
NCT07321925
NCT07314684
NCT06735924
Lead Sponsor
Royal College of Surgeons in Ireland - Medical University of Bahrain
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions